Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Intoxication | Research

Changes in all-cause and cause-specific mortality during the first year of the COVID-19 pandemic in Minnesota: population-based study

Authors: Rozalina G. McCoy, Ronna L. Campbell, Aidan F. Mullan, Colin M. Bucks, Casey M. Clements, R. Ross Reichard, Molly M. Jeffery

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

The COVID-19 pandemic resulted in unprecedented increases in mortality in the U.S. and worldwide. To better understand the impact of the COVID-19 pandemic on mortality in the state of Minnesota, U.S.A., we characterize the changes in the causes of death during 2020 (COVID-19 period), compared to 2018–2019 (baseline period), assessing for differences across ages, races, ethnicities, sexes, and geographic characteristics.

Methods

Longitudinal population-based study using Minnesota death certificate data, 2018–2020. Using Poisson regression models adjusted for age and sex, we calculated all-cause and cause-specific (by underlying causes of death) mortality rates per 100,000 Minnesotans, the demographics of the deceased, and years of life lost (YLL) using the Chiang’s life table method in 2020 relative to 2018–2019.

Results

We identified 89,910 deaths in 2018–2019 and 52,030 deaths in 2020. The mean daily mortality rate increased from 123.1 (SD 11.7) in 2018–2019 to 144.2 (SD 22.1) in 2020. COVID-19 comprised 9.9% of deaths in 2020. Other categories of causes of death with significant increases in 2020 compared to 2018–2019 included assault by firearms (RR 1.68, 95% CI 1.34–2.11), accidental poisonings (RR 1.49, 95% CI 1.37–1.61), malnutrition (RR 1.48, 95% CI 1.17–1.87), alcoholic liver disease (RR, 95% CI 1.14–1.40), and cirrhosis and other chronic liver diseases (RR 1.28, 95% CI 1.09–1.50). Mortality rates due to COVID-19 and non-COVID-19 causes were higher among racial and ethnic minority groups, older adults, and non-rural residents.

Conclusions

The COVID-19 pandemic was associated with a 17% increase in the death rate in Minnesota relative to 2018–2019, driven by both COVID-19 and non-COVID-19 causes. As the COVID-19 pandemic enters its third year, it is imperative to examine and address the factors contributing to excess mortality in the short-term and monitor for additional morbidity and mortality in the years to come.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ahmad FB, Cisewski JA, Minino A, Anderson RN. Provisional mortality data - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(14):519–22.CrossRef Ahmad FB, Cisewski JA, Minino A, Anderson RN. Provisional mortality data - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(14):519–22.CrossRef
2.
go back to reference Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol. 2021;77(2):159–69.CrossRef Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol. 2021;77(2):159–69.CrossRef
3.
go back to reference Faust JS, Krumholz HM, Du C, Mayes KD, Lin Z, Gilman C, et al. All-cause excess mortality and COVID-19-related mortality among US adults aged 25-44 years, march-July 2020. JAMA. 2021;325(8):785–7.CrossRef Faust JS, Krumholz HM, Du C, Mayes KD, Lin Z, Gilman C, et al. All-cause excess mortality and COVID-19-related mortality among US adults aged 25-44 years, march-July 2020. JAMA. 2021;325(8):785–7.CrossRef
4.
go back to reference Faust JS, Du C, Mayes KD, Li S-X, Lin Z, Barnett ML, et al. Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic, march-august 2020. JAMA. 2021;326(1):84–6.CrossRef Faust JS, Du C, Mayes KD, Li S-X, Lin Z, Barnett ML, et al. Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic, march-august 2020. JAMA. 2021;326(1):84–6.CrossRef
5.
go back to reference Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L, Taylor DDH. Excess deaths from COVID-19 and other causes, march-July 2020. JAMA. 2020;324(15):1562–4.CrossRef Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L, Taylor DDH. Excess deaths from COVID-19 and other causes, march-July 2020. JAMA. 2020;324(15):1562–4.CrossRef
6.
go back to reference Ran J, Zhao S, Han L, Ge Y, Chong MKC, Cao W, et al. Increase in diabetes mortality associated with COVID-19 pandemic in the U.S. Diabetes Care. 2021;44(7):e146–e7.CrossRef Ran J, Zhao S, Han L, Ge Y, Chong MKC, Cao W, et al. Increase in diabetes mortality associated with COVID-19 pandemic in the U.S. Diabetes Care. 2021;44(7):e146–e7.CrossRef
7.
go back to reference Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829–30.CrossRef Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829–30.CrossRef
8.
go back to reference Rossen LM, Branum AM, Ahmad FB, Sutton P, Anderson RN. Excess deaths associated with COVID-19, by Age and race and Ethnicity - United States, January 26-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(42):1522–7.CrossRef Rossen LM, Branum AM, Ahmad FB, Sutton P, Anderson RN. Excess deaths associated with COVID-19, by Age and race and Ethnicity - United States, January 26-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(42):1522–7.CrossRef
9.
go back to reference Simon P, Ho A, Shah MD, Shetgiri R. Trends in mortality from COVID-19 and other leading causes of death among Latino vs white individuals in Los Angeles County, 2011-2020. JAMA. 2021;326(10):973–4.CrossRef Simon P, Ho A, Shah MD, Shetgiri R. Trends in mortality from COVID-19 and other leading causes of death among Latino vs white individuals in Los Angeles County, 2011-2020. JAMA. 2021;326(10):973–4.CrossRef
10.
go back to reference Weinberger DM, Chen J, Cohen T, Crawford FW, Mostashari F, Olson D, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, march to may 2020. JAMA Intern Med. 2020;180(10):1336–44.CrossRef Weinberger DM, Chen J, Cohen T, Crawford FW, Mostashari F, Olson D, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, march to may 2020. JAMA Intern Med. 2020;180(10):1336–44.CrossRef
11.
go back to reference Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, march-April 2020. JAMA. 2020;324(5):510–3.CrossRef Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, march-April 2020. JAMA. 2020;324(5):510–3.CrossRef
12.
go back to reference Acosta AM, Garg S, Pham H, Whitaker M, Anglin O, O'Halloran A, et al. Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from march 2020 to February 2021. JAMA Netw Open. 2021;4(10):e2130479.CrossRef Acosta AM, Garg S, Pham H, Whitaker M, Anglin O, O'Halloran A, et al. Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from march 2020 to February 2021. JAMA Netw Open. 2021;4(10):e2130479.CrossRef
13.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7.CrossRef
16.
17.
go back to reference Heron M. Deaths: Leading Causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77. Heron M. Deaths: Leading Causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.
19.
go back to reference Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4(2):213–26.CrossRef Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4(2):213–26.CrossRef
20.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300.
21.
go back to reference Frome EL, Checkoway H. Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985;121(2):309–23.CrossRef Frome EL, Checkoway H. Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985;121(2):309–23.CrossRef
23.
go back to reference Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and Ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379–81. Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and Ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379–81.
24.
go back to reference CDC. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic: Center for Preparedness and Response. In: Center for Disease Control and Prevention. US: Dept Of Health And Human Services; 2020. Updated March 27, 2020; Cited 2022 March 18. Available from: https://emergency.cdc.gov/han/2020/han00438.asp#. CDC. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic: Center for Preparedness and Response. In: Center for Disease Control and Prevention. US: Dept Of Health And Human Services; 2020. Updated March 27, 2020; Cited 2022 March 18. Available from: https://​emergency.​cdc.​gov/​han/​2020/​han00438.​asp#.
25.
go back to reference Bolinski RS, Walters S, Salisbury-Afshar E, Ouellet LJ, Jenkins WD, Almirol E, et al. The impact of the COVID-19 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings. Int J Environ Res Public Health. 2022;19(4):2230. Bolinski RS, Walters S, Salisbury-Afshar E, Ouellet LJ, Jenkins WD, Almirol E, et al. The impact of the COVID-19 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings. Int J Environ Res Public Health. 2022;19(4):2230.
26.
go back to reference Huskamp HA, Busch AB, Uscher-Pines L, Barnett ML, Riedel L, Mehrotra A. Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA. 2020;324(23):2440–2.CrossRef Huskamp HA, Busch AB, Uscher-Pines L, Barnett ML, Riedel L, Mehrotra A. Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA. 2020;324(23):2440–2.CrossRef
27.
go back to reference Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-lancet commission. Lancet. 2022;399(10324):555–604.CrossRef Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-lancet commission. Lancet. 2022;399(10324):555–604.CrossRef
30.
go back to reference Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework. Milbank Quarterly. 2020;98(3):700–46.CrossRef Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework. Milbank Quarterly. 2020;98(3):700–46.CrossRef
33.
go back to reference Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942-e.CrossRef Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942-e.CrossRef
35.
go back to reference Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology. 2020;159(2):768–71.e3.CrossRef Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology. 2020;159(2):768–71.e3.CrossRef
36.
go back to reference Ge J, Pletcher MJ, Lai JC. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study. Gastroenterology. 2021;161(5):1487–501.e5.CrossRef Ge J, Pletcher MJ, Lai JC. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study. Gastroenterology. 2021;161(5):1487–501.e5.CrossRef
37.
go back to reference Eskelinen K, Hartikainen S, Nykänen I. Is loneliness associated with malnutrition in older people? Int J Gerontol. 2016;10(1):43–5.CrossRef Eskelinen K, Hartikainen S, Nykänen I. Is loneliness associated with malnutrition in older people? Int J Gerontol. 2016;10(1):43–5.CrossRef
40.
go back to reference Case A, Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci. 2015;112(49):15078–83.CrossRef Case A, Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci. 2015;112(49):15078–83.CrossRef
41.
go back to reference Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020;324(1):96–9.CrossRef Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020;324(1):96–9.CrossRef
42.
go back to reference Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, et al. The covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020;383(7):691–3.CrossRef Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, et al. The covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020;383(7):691–3.CrossRef
43.
go back to reference Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76(3):280–8.CrossRef Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76(3):280–8.CrossRef
44.
go back to reference Shiels MS, Haque AT, Haozous EA, Albert PS, Almeida JS, García-Closas M, et al. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020. Ann Intern Med. 2021;174(12):1693–99. Shiels MS, Haque AT, Haozous EA, Albert PS, Almeida JS, García-Closas M, et al. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020. Ann Intern Med. 2021;174(12):1693–99.
45.
go back to reference Mackey K, Ayers CK, Kondo KK, Saha S, Advani SM, Young S, et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths : a systematic review. Ann Intern Med. 2021;174(3):362–73.CrossRef Mackey K, Ayers CK, Kondo KK, Saha S, Advani SM, Young S, et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths : a systematic review. Ann Intern Med. 2021;174(3):362–73.CrossRef
46.
go back to reference Zalla LC, Martin CL, Edwards JK, Gartner DR, Noppert GA. A geography of risk: structural racism and coronavirus disease 2019 mortality in the United States. Am J Epidemiol. 2021;190(8):1439–46.CrossRef Zalla LC, Martin CL, Edwards JK, Gartner DR, Noppert GA. A geography of risk: structural racism and coronavirus disease 2019 mortality in the United States. Am J Epidemiol. 2021;190(8):1439–46.CrossRef
47.
go back to reference Holden TM, Simon MA, Arnold DT, Halloway V, Gerardin J. Structural racism and COVID-19 response: higher risk of exposure drives disparate COVID-19 deaths among black and Hispanic/Latinx residents of Illinois, USA. BMC Public Health. 2022;22(1):312.CrossRef Holden TM, Simon MA, Arnold DT, Halloway V, Gerardin J. Structural racism and COVID-19 response: higher risk of exposure drives disparate COVID-19 deaths among black and Hispanic/Latinx residents of Illinois, USA. BMC Public Health. 2022;22(1):312.CrossRef
48.
go back to reference McClure ES, Vasudevan P, Bailey Z, Patel S, Robinson WR. Racial capitalism within public health—how occupational settings drive COVID-19 disparities. Am J Epidemiol. 2020;189(11):1244–53.CrossRef McClure ES, Vasudevan P, Bailey Z, Patel S, Robinson WR. Racial capitalism within public health—how occupational settings drive COVID-19 disparities. Am J Epidemiol. 2020;189(11):1244–53.CrossRef
49.
go back to reference Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–7.CrossRef Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–7.CrossRef
50.
go back to reference Lopez L III, Hart LH III, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA. 2021;325(8):719–20.CrossRef Lopez L III, Hart LH III, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA. 2021;325(8):719–20.CrossRef
51.
go back to reference Wiltz JL, Feehan AK, Molinari NM, Ladva CN, Truman BI, Hall J, et al. Racial and ethnic disparities in receipt of medications for treatment of COVID-19 - United States, march 2020-august 2021. MMWR Morb Mortal Wkly Rep. 2022;71(3):96–102.CrossRef Wiltz JL, Feehan AK, Molinari NM, Ladva CN, Truman BI, Hall J, et al. Racial and ethnic disparities in receipt of medications for treatment of COVID-19 - United States, march 2020-august 2021. MMWR Morb Mortal Wkly Rep. 2022;71(3):96–102.CrossRef
52.
go back to reference Graves JM, Mackelprang JL, Amiri S, Abshire DA. Barriers to telemedicine implementation in southwest tribal communities during COVID-19. J Rural Health. 2021;37(1):239–41.CrossRef Graves JM, Mackelprang JL, Amiri S, Abshire DA. Barriers to telemedicine implementation in southwest tribal communities during COVID-19. J Rural Health. 2021;37(1):239–41.CrossRef
53.
go back to reference Rodriguez-Lonebear D, Barceló NE, Akee R, Carroll SR. American Indian reservations and COVID-19: correlates of early infection rates in the pandemic. J Public Health Manag Pract. 2020;26(4):371–77. Rodriguez-Lonebear D, Barceló NE, Akee R, Carroll SR. American Indian reservations and COVID-19: correlates of early infection rates in the pandemic. J Public Health Manag Pract. 2020;26(4):371–77.
54.
go back to reference Jiang DH, McCoy RG. Planning for the post-COVID syndrome: how payers can mitigate long-term complications of the pandemic. J Gen Intern Med. 2020;35(10):3036–9.CrossRef Jiang DH, McCoy RG. Planning for the post-COVID syndrome: how payers can mitigate long-term complications of the pandemic. J Gen Intern Med. 2020;35(10):3036–9.CrossRef
Metadata
Title
Changes in all-cause and cause-specific mortality during the first year of the COVID-19 pandemic in Minnesota: population-based study
Authors
Rozalina G. McCoy
Ronna L. Campbell
Aidan F. Mullan
Colin M. Bucks
Casey M. Clements
R. Ross Reichard
Molly M. Jeffery
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-14743-z

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue